bimotrim co injection solution for injection
bimeda chemicals ltd - sulfadoxine, trimethoprim - solution for injection - antimicrobial - cattle, horses
trisullak 200mg/40mg per ml solution for injection (im)
fanfreluche enterprises inc. - sulfadoxine , trimethoprim (vet.) - solution for injection (im) - 200mg/40mg per ml
intertrim la solution for i/m injection
interchemie werken de adelaar b.v. - sulfadoxine, trimethoprim - solution for i/m injection - 200mg/ml+ 40mg/ml
bimotrim co injection solution for injection
bimeda animal health limited - sulfadoxine, trimethoprim - solution for injection - antimicrobial - cattle, horses
none 200 mg/40 mg per ml solution for injection (im)
sulfadoxine , trimethoprim (vet) - solution for injection (im) - 200 mg/40 mg per ml
sulfamethoxazole and trimethoprim tablet
redpharm drug, inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x), sulfamethoxazole (unii: je42381tnv) (sulfamethoxazole - unii:je42381tnv) - trimethoprim 160 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets, usp and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. urinary tract infections for the treatment of urinary tract infections due to susceptible strains of the following organisms: escherichia coli, klebsiella species, enterobacter species, morganella morganii, proteus mirabilis and proteus vulgaris. it is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than the combination. acute otitis m
polymyxin b sulfate and trimethoprim solution
akorn - trimethoprim sulfate (unii: e377mf8eq8) (trimethoprim - unii:an164j8y0x), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - trimethoprim 1 mg in 1 ml - polymyxin b sulfate and trimethoprim ophthalmic solution is indicated in the treatment of surface ocular bacterial infections, including acute bacterial conjunctivitis, and blepharoconjunctivitis, caused by susceptible strains of the following microorganisms: staphylococcus aureus, staphylococcus epidermidis, streptococcus pneumoniae, streptococcus viridans, haemophilus influenza and pseudomonas aeruginosa. * *efficacy for this organism in this organ system was studied in fewer than 10 infections. polymyxin b sulfate and trimethoprim ophthalmic solution is contraindicated in patients with known hypersensitivity to any of its components.
trimethoprim tablet
actavis pharma, inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 100 mg
trimethoprim tablet
avpak - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 100 mg
trimethoprim tablet
teva pharmaceuticals usa, inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 100 mg